Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29

COVIDIEN PLC (COV)

21
End-of-day quote. End-of-day quote Nyse - 01/26
106.71 USD   -1.26%
05/19DJMedtronic Expects Profit at High End of Outlook
05/19DJMedtronic Expects Profit at High End of Outlook
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--4th Update
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Company
Covidien Plc engages in the development, manufacture and sale of healthcare products for use in clinical and home settings.It operates through three segments: Medical Devices, Pharmaceuticals and Medical Supplies.The Medical Devices segment includes the development, manufacture and sale of... 
More about the company
Latest news on COVIDIEN PLC
05/19DJMedtronic Expects Profit at High End of Outlook
05/19DJMedtronic Expects Profit at High End of Outlook
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--4th Update
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
02/17 S&P 500 ends at record high on Greece hopes, as bonds drop
02/17DJMedtronic Tops Expectations On Sales Strength -- Update
02/17DJMedtronic Files 8K - Regulation FD
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC

- No features available -

More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
05/21 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
05/18 Tracking David Einhorn's Portfolio - Q1 2015 Update
05/15 Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2015 Update
04/23 Pfizer's Once And Future Deals
03/09 Why Medtronic-Covidien Deal Will Lead To Strong 2015 Performance
Comments 
Advertisement
Chart COVIDIEN PLC
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials